Strattera (atomoxetine) is a prescription drug that’s used to treat attention deficit hyperactivity disorder (ADHD). Strattera comes as an oral capsule. Strattera is used in adults and certain ...

However, your doctor or pharmacist may have suggested a different schedule that is more appropriate for you. Take it regularly and continuously to maintain its beneficial effects. Do not use more of ...

(RTTNews) - Dr. Reddy's Laboratories Ltd. (RDY, DRREDDY) announced Wednesday the launch of Atomoxetine Capsules, USP, a therapeutic equivalent generic version of Strattera (atomoxetine) Capsules in ...

Sun Pharmaceutical Industries Ltd. announced that USFDA has granted its subsidiary an approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Strattera , atomoxetine ...

In a BSE filing, Aurobindo Pharma said it “has received final approval from the US Food & Drug Administration (USFDA) to manufacture Atomoxetine capsules, 10 mg, 18 mg, 25 mg, 40 mg, 60 mg, 80 mg and ...

MORRISTOWN, N.J., Sept 01, 2010 /PRNewswire via COMTEX/ -- Actavis has received approval from the U.S. Food & Drug Administration to market Atomoxetine HCl capsules for the treatment of attention ...

Glenmark Pharmaceuticals has received final approval from the US health regulator for generic version of Strattera Capsules. (IE) Glenmark Pharmaceuticals has received final approval from the US ...

This activity is part of an ongoing CME/CE initiative to provide information on labeling changes reported by the FDA. Activities of this nature will be posted on Medscape on a weekly basis. On June 3, ...

HYDERABAD, India & Princeton, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today ...